Research Article

Comparison of IORT (Radical and Boost Dose) and EBRT in Terms of Disease-Free Survival and Overall Survival according to Demographic, Pathologic, and Biological Factors in Patients with Breast Cancer

Table 2

Clinical, pathologic, and treatment-related characteristics of the EBRT and boost-IORT groups.

EBRTElectron boostX-ray -boostTotal
N%N%N%N%
6571007061002831001646100

Stage
 18913.50132193010.6025124.70
 242865.1043061.8016859.40102657.40
 314021.3013419.30853035917.90
 Total6571006961002831001636100

Size
31253.1037458.3011542.4080160.00
 2.5 = 3 cm14424.509915.403914.4028217.00
13222.4016926.3011743.2041823.10
 Total5881006421002711001501100

Grade
 1548.60477.003112.3013210.30
 233653.4037956.809738.3081253.50
 32393824136.1012549.4060536.20
 Total6291006671002531001549100

LVI
 Positive2544232849.9011872.4070043.00
 Negative3515832950.104527.6072557.00
 Total6051006571001631001425100

Ki67
3211.8017629.002335.9023127.10
23988.2043171.004164.1071172.90
 Total27110060710064100942100

ER
 Positive37276.4051772.3017572.30106477.30
 Negative11523.6015827.706727.7034022.70
 Total4871006751002421001404100

HER2
 Positive9123.808914.006825.5024819.10
 Negative29276.2054786.0019974.50103880.90
 Total3831006361002671001286100

Age
16024.9013520.908831.1038319.80
 =40–5019330.0023636.5010035.3052931.90
29045.1027542.609533.6066048.30
 Total6431006461002831001572100

Histology
 IDC59190.9044964.5016162.60120174.90
 ILC253.808311.903513.601438.90
 IDC + DCIS233.509313.403915.201559.70
 IDC + ILC20.30608.60197.40815.10
 Others91.40111.6031.20231.40

Adjuvant therapy
 CT + HT24568.4043572.0016670.0084670.60
 HT alone339.20193.1062.50584.80
 CT alone8022.3015024.806527.4029524.60
 Total3581006041002371001199100